| Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells. | |
| | |
MedLine Citation:
|
PMID: 22910273 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Glioblastoma, the deadliest brain tumor in humans, responds poorly to conventional chemotherapeutic agents because of existence of highly chemoresistant human brain tumor stem cells (HBTSC). An effective therapeutic strategy is urgently needed to target HBTSC as well as other glioblastoma cells. We explored synergistic efficacy of a low dose of curcumin (CCM) and a low dose of paclitaxel (PTX) in HBTSC and human glioblastoma LN18 (p53 mutant and PTEN proficient) and U138MG (p53 mutant and PTEN mutant) cells. The highest expression of the cancer stem cell markers aldehyde dehydrogenase 1 (ALDH1) and CD133 occurred in HBTSC when compared with LN18 and U138MG cells. Combination of 20μM CCM and 10nM PTX worked synergistically and more effectively than either drug alone in decreasing viability in all cells. Combination of CCM and PTX was highly effective in inducing both morphological and biochemical features of apoptosis. Apoptosis required activation of caspase-8, cleavage of Bid to tBid, increase in Bax:Bcl-2 ratio, and mitochondrial release of cytochrome c, Smac, and apoptosis-inducing factor (AIF). Phosphorylation of Bcl-2 following combination therapy appeared to promote Bax homodimerization and mitochondrial release of pro-apoptotic factors into the cytosol. Increases in activities cysteine proteases confirmed the completion of apoptotic process. Combination therapy inhibited invasion of cells, reduced expression of survival and proliferation factors and also angiogenic factors, and prevented HBTSC, LN18, and U138MG cells from promoting network formation. Collectively, the combination of CCM and PTX worked as a promising therapy for controlling the growth of HBTSC and other glioblastoma cells. |
| | |
Authors:
|
Md Motarab Hossain; Naren L Banik; Swapan K Ray |
Related Documents
:
|
17398113 - Synthetic surfaces as artificial antigen presenting cells in the study of t cell recept... 20519653 - A role for lysosomal-associated protein transmembrane 5 in the negative regulation of s... 16258153 - A practical approach to the detection of prognostically significant genomic aberrations... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-8-13 |
Journal Detail:
|
Title: Neurochemistry international Volume: - ISSN: 1872-9754 ISO Abbreviation: Neurochem. Int. Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-8-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8006959 Medline TA: Neurochem Int Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012. Published by Elsevier Ltd. |
Affiliation:
|
Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC, United States. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Contributing Factors for Cancellations of Outpatient Pediatric Urology Procedures: Single Center Exp...
Next Document: Brain regions involved in the retrieval of spatial and episodic details associated with a familiar e...